Table 2 Patient characteristics
All ages (N = 87) | Age group 4-7 (N = 10) | Age group 8-12 (N = 30) | Age group 13-18+ (N = 47) | |||||
|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | |
Gender | ||||||||
Female | 43 | 49% | 4 | 40% | 16 | 53% | 23 | 49% |
Male | 44 | 51% | 6 | 60% | 14 | 47% | 24 | 51% |
Treated with Agalsidase Alfa | ||||||||
No | 37 | 43% | 7 | 70% | 17 | 57% | 13 | 28% |
Yes | 50 | 57% | 3 | 30% | 13 | 43% | 34 | 72% |
FOS MSSI | ||||||||
Mild (<20) | 81 | 93% | 10 | 100% | 27 | 90% | 44 | 94% |
Moderate (20-40) | 3 | 3% | 0 | 0% | 1 | 3% | 2 | 4% |
Missing | 3 | 3% | 0 | 0% | 2 | 7% | 1 | 2% |